Indaptus Therapeutics - INDP Company Short-Term Debt
The asset value of Indaptus Therapeutics (INDP) reflected in the chart demonstrates the dynamics of a company that strictly adheres to medical codes regarding biohazardous waste disposal during trials. The enterprise minimizes environmental impact by optimizing water and chemical consumption, which constitutes 0.00. The business is based on creating universal cancer treatment methods for oncology centers, aiming for a significant share of the global biotechnology sector.
%20Company%20Current%20Liabilities&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_INDP_-_Indaptus-Therapeutics_-_Company-Current-Liabilities "INDP Indaptus Therapeutics: Company Short-Term Debts in the range 07/04/2022 - 10/28/2026 | 👁️GURU.Markets👁️")
Indaptus Corp - analytical breakdowns and key metrics (INDP)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Total Debt to Capital Indaptus Therapeutics|INDP - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Indaptus Therapeutics|INDP - Company Total Debt|Debt to Book Capitalization Ratio Indaptus Therapeutics, Inc.|INDP - Company Long-Term Liabilities|Company Current Liabilities Indaptus Therapeutics
Fundamental company valuation:Indaptus Therapeutics, Inc. - INDP
This indicator aggregates the total credit obligations of Indaptus Therapeutics (INDP) with maturities of up to twelve months, capturing the operational pressure on liquidity. The stability of current short-term liabilities confirms the resilience of non-cyclical tumor immunotherapy developments against macroeconomic shocks, allowing investors to assess the efficiency of debt capital management within the context of long-term oncology project financing via this chart.
Competitor analysis
Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Company Short-Term Debts UPB (Upstream Bio Corp)|ZBIO: Short-Term Debt Volume|Company Short-Term Debt Immunome, Inc.|gossamerbio.com (GOSS) - Company Short-Term Indebtedness|Company Short-Term Debts KalVista Pharmaceuticals, Inc. (KALV)|Company Short-Term Indebtedness Septerna, Inc.|Company Short-Term Debts PVLA|Company Short-Term Debts SVRA (Savara Pharma)|Rigel Pharmaceuticals (RIGL) - Company Short-Term Debt|ANAB - Current Liabilities|Company Current Liabilities Astria Therapeutics, Inc. ATXS|enGene Holdings Inc (ENGN) - Amount of Current Liabilities|RAPT: Company Current Liabilities|JBIO (Aerovate Therapeutics) - Company Short-Term Debts|ACRS: Company Short-Term Debt|Short-Term Debt Volume kyvernatx.com (KYTX)|Tiziana Life Sciences Ltd (TLSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Cabaletta Bio Inc. CABA|Company Current Liabilities Ventyx Bio (VTYX)|Amount of Current Liabilities Theratechnologies, Inc THTX|Company Short-Term Debts Avalo Therapeutics, Inc (AVTX)|ELDN - Company Short-Term Loans and Borrowings|Company Short-Term Debts AGEN|CLYM (Climb Bio Inc.) - Short-Term Debt|ZURA - Company Short-Term Debt|Company Short-Term Loans and Borrowings aTyr Pharmaceuticals|Company Short-Term Debts ADAG|Company Short-Term Debts IMA (ikenaoncology.com)|Shattuck Labs (STTK) - Company Short-Term Debt|Current Liabilities Equillium Inc EQ|CNTB (Connect Pharma) - Company Short-Term Debts|Immunic, Inc. (IMUX) - Short-Term Debt|ATRA: Company Current Liabilities|Company Short-Term Debts InflaRx|X4 Pharmaceuticals, Inc. (XFOR) - Company Current Liabilities|Amount of Current Liabilities Adicet|CELU (Celularity Inc.) - Company Short-Term Debts|Short-Term Debt Volume INmune Bio Corporation (INMB)|Barinthus Biotherapeutics - Company Short-Term Debts|kezarlifesciences.com - Company Current Liabilities|Company Short-Term Debt SABS (SAB Biotherapeutics, Inc.)|AKTX - Short-Term Debt Volume|enlivex.com - Company Short-Term Debts|QTTB (Q32 Bio) - Short-Term Debt Volume|Company Short-Term Debt GeoVax Labs, Inc. (GOVX)|Company Short-Term Indebtedness edesabiotech.com|Company Short-Term Debts iBio IBIO|Company Short-Term Indebtedness CARM (carismatx.com)|XTL Biopharmaceuticals, Ltd. (XTLB) - Company Short-Term Debt|Bolt Biotherapeutics Inc. - Current Liabilities|Company Short-Term Debt HCW Biologics Inc|APVO - Current Liabilities|Company Short-Term Debts AIM ImmunoTech Inc. AIM|Aditxt, Inc. (ADTX) - Company Short-Term Loans and Borrowings|GRI (GRI Bio Corp) - Company Short-Term Debts|Company Short-Term Debts XRTX|Vyome Holdings Inc (HIND) - Company Short-Term Debt|Company Short-Term Loans and Borrowings REVB (revbiosciences.com)|Scinai Immunotherapeutics Ltd. - Company Short-Term Debt|Company Current Liabilities CalciMedica Inc CALI|Affimed Therapeutics - Company Short-Term Debts|Allakos Inc. (ALLK) - Company Short-Term Debts|Company Current Liabilities hookipapharma.com HOOK|IGM Biosciences (IGMS) - Company Short-Term Loans and Borrowings|ITOS: Company Short-Term Debts|Short-Term Debt Volume OCEA|Company Short-Term Debt TCBP (TC BioPharm (Holdings) PLC)|Company Current Liabilities THRD (Third Harmonic Bio Inc)